ROCKVILLE, MD, October 6, 2008 – Ariadne today announced that World Fusion has become
Ariadne’s exclusive distributor in Japan, and will serve as support center for its patent-pending
MedScan® technology and Pathway Studio® product line. Powered by MedScan technology,
Pathway Studio enables scientists to control vast amounts of publicly available information and
supplements all stages of research, from preparing grant and IND applications, through
experimental planning, to the analysis and interpretation of experimental results.
“Our customers have been using Pathway Studio in different fields: RNAi, target and biomarker
discovery, disease mechanism research, and many others to organize published information and use
it to supplement experimental work and validate hypotheses”, said Kozo Kawahara, President of
World Fusion. “Our corporate clients prefer Ariadne’s Pathway Studio for its unique data content
and advanced data management capability”.
“World Fusion has been successfully reselling Ariadne’s products to Japanese biotechnology and
pharmaceutical companies for over four years”, said Ilya Mazo, President of Ariadne. “Now with
Pathway Studio version 6, our new generation product specifically designed for ease of use and
powerful experimental data analysis capability, we expect World Fusion will expand to the
academic market and will be successful as exclusive distributor”.
ARIADNE (www.ariadnegenomics.com) Pathway Studio software is used worldwide as a
comprehensive solution for analysis and searching of pathways and molecular interaction
information. Ariadne offers desktop and enterprise editions of Pathway Studio which are supported
by several commercial and publicly available molecular interaction databases including ResNet
Mammalian and ResNet Plant. Pathway Studio is powered by MedScan Technology, which
researchers can use to edit and enhance database content from the current literature and from
About World Fusion
World Fusion (http://www.w-fusion.com/) has been an active player on the Japanese bioinformatics
market since 1996, as a software developer and solution provider for pharmaceutical research.
Recently World Fusion expanded its interests into the field of pharmacogenomics, providing
genomics and medical data analysis from the point of view which is closer to clinical area.